Biologics for Crohn's Go Head to Head

(MedPage Today) -- Ustekinumab (Stelara) or adalimumab (Humira) were similarly effective as induction or maintenance therapy for moderate to severe Crohn's disease, according to the randomized SEAVUE trial. In an intention-to-treat analysis involving...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news